Personalized Medicine: A New Normal for Therapeutic Success

被引:4
|
作者
Sarvan, M. S. [1 ]
Nori, Lakshmi Prasanthi [2 ]
机构
[1] Vignan Coll Pharm, Dept Pharm, Vadlamudi, India
[2] Vignans Fdn Sci Technol & Res Deemed Univ, Dept Pharmaceut Sci, Guntur 522213, Andhra Pradesh, India
关键词
Personalized medicine; precision medicine; genomics; biomarkers; epigenetics; DNA METHYLATION BIOMARKERS; DISEASES; PHARMACOGENOMICS; ASSOCIATION; EPIGENETICS; VALIDATION; METABOLISM; EXPRESSION;
D O I
10.36468/pharmaceutical-sciences.790
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this article is to provide a framework for understanding the principles of personalized and precision medicine. Since the advent of the human genome project in 1990, the approach to precision and accurate medicine has been changed. This turns the practice from the "one size fits all" paradigm into one that tailors patient identification, diagnosis and treatment. Personalized medicine has been a disputed vision of the future for two decades. A humanized approach to personalized medicine will offer the possibility of leveraging the physiology of processes and its application of personalized, predictive, participatory, precision and preventive P5 medicine. The predictive variables for the progression of a disease should be investigated within communities to determine preventive measures for at risk people and healthcare can be customized and participative. Accurate diagnosis, surveillance and treatment of diseases includes developments in the identification of biomarkers, the subsequent development of reliable signatures that suit complex disease states, as well as medical approaches that can be continually modified and modulated for dosage and medication selection. This review illustrates significant breakthroughs in the advancement of emerging technology and obstacles of personalized and precise medicine. It will create groundbreaking capabilities in the realization of fully individualized patient care.
引用
收藏
页码:416 / 429
页数:14
相关论文
共 50 条
  • [1] Therapeutic Dilemma in Personalized Medicine
    El Desoky, Ehab S.
    CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY, 2022, 17 (02) : 94 - 102
  • [2] The challenge of developing new therapeutic agents in the era of personalized medicine
    Campone, M.
    Frenel, J-S
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2012, 36 (04): : 228 - 232
  • [3] Personalized medicine: Seven keys to success
    Little, S
    SCIENTIST, 2006, 20 (01): : 75 - 76
  • [4] Therapeutic strategies at the time of personalized medicine
    Eigenmann, P.
    REVUE FRANCAISE D ALLERGOLOGIE, 2023, 63 (03):
  • [5] The Use of Personalized Medicine in Pancreatic Ductal Adenocarcinoma (PDAC): New Therapeutic Opportunities
    Mendes, Ines
    Vale, Nuno
    FUTURE PHARMACOLOGY, 2024, 4 (04): : 934 - 954
  • [6] Exploring New Therapeutic Pathways in Pulmonary Hypertension Metabolism, Proliferation, and Personalized Medicine
    George, M. Patricia
    Gladwin, Mark T.
    Graham, Brian B.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2020, 63 (03) : 279 - 292
  • [7] Therapeutic Targets and Personalized Medicine in Cardiac Disease
    Vafiadaki, Elizabeth
    Turnbull, Irene C.
    Sanoudou, Despina
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (11):
  • [8] New tech for personalized medicine
    Lake, Francesca
    BIOTECHNIQUES, 2019, 66 (02) : 59 - 59
  • [9] A new target for personalized medicine
    Hunter, Philip
    EMBO REPORTS, 2011, 12 (12) : 1229 - 1232
  • [10] New Radionuclides for Personalized Medicine
    Zherebchevsky V.I.
    Alekseev I.E.
    Lazareva T.V.
    Maltsev N.A.
    Nauruzbayev D.K.
    Nesterov D.G.
    Prokofiev N.A.
    Rahmatullina A.R.
    Torilov S.Y.
    Bulletin of the Russian Academy of Sciences: Physics, 2021, 85 (10): : 1128 - 1135